# RDF export of group: Publication
<http://ctro/data#Publication_110356> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Publication> .
<http://ctro/data#Publication_110356> <http://www.w3.org/2000/01/rdf-schema#label> "Publication" .
<http://ctro/data#Publication_110356> <http://ctro/data#hasTitle> "Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control : a randomized trial ." .
<http://ctro/data#Publication_110356> <http://ctro/data#hasAuthor> "Esposito K" .
<http://ctro/data#Publication_110356> <http://ctro/data#hasPublicationYear> "2008" .
<http://ctro/data#Publication_110356> <http://ctro/data#hasJournal> "Ann Intern Med ." .
<http://ctro/data#Publication_110356> <http://ctro/data#hasPMID> "18936501" .
<http://ctro/data#Publication_110356> <http://ctro/data#describes> <http://ctro/data#ClinicalTrial_110371> .
<http://ctro/data#Publication_110356> <http://ctro/data#hasAuthor> "Ciotola M" .
<http://ctro/data#Publication_110356> <http://ctro/data#hasAuthor> "Maiorino MI" .
<http://ctro/data#Publication_110356> <http://ctro/data#hasAuthor> "Gualdiero R" .
<http://ctro/data#Publication_110356> <http://ctro/data#hasAuthor> "Schisano B" .
<http://ctro/data#Publication_110356> <http://ctro/data#hasAuthor> "Ceriello A" .
<http://ctro/data#Publication_110356> <http://ctro/data#hasAuthor> "Beneduce F" .
<http://ctro/data#Publication_110356> <http://ctro/data#hasAuthor> "Feola G" .
<http://ctro/data#Publication_110356> <http://ctro/data#hasAuthor> "Giugliano D" .
# RDF export of group: ClinicalTrial
<http://ctro/data#ClinicalTrial_110371> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#ClinicalTrial> .
<http://ctro/data#ClinicalTrial_110371> <http://www.w3.org/2000/01/rdf-schema#label> "ClinicalTrial" .
<http://ctro/data#ClinicalTrial_110371> <http://ctro/data#hasObjectiveDescription> "To compare the clinical efficacy and safety of bedtime NPL insulin or insulin glargine in patients with type 2 diabetes who had suboptimal glycemic control while receiving stable doses of metformin and sulfonylurea ." .
<http://ctro/data#ClinicalTrial_110371> <http://ctro/data#hasNumberPatientsCT> "116" .
<http://ctro/data#AllocationRatio_110375> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AllocationRatio> .
<http://ctro/data#CTAnalysisApproach_110376> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTAnalysisApproach> .
<http://ctro/data#ClinicalTrial_110371> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized> .
<http://ctro/data#ClinicalTrial_110371> <http://ctro/data#hasConclusionComment> "Similar glycemic control occurred with the addition of NPL or glargine insulin to oral regimens in patients with poorly controlled type 2 diabetes ." .
<http://ctro/data#ClinicalTrial_110371> <http://ctro/data#hasArm> <http://ctro/data#Arm_110431> .
<http://ctro/data#ClinicalTrial_110371> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes> .
<http://ctro/data#ClinicalTrial_110371> <http://ctro/data#hasPopulation> <http://ctro/data#Population_110389> .
<http://ctro/data#ClinicalTrial_110371> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_110542> .
<http://ctro/data#EvidenceQuality_110383> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EvidenceQuality> .
<http://ctro/data#ClinicalTrial_110371> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel> .
<http://ctro/data#ClinicalTrial_110371> <http://ctro/data#hasConclusionComment> "Hypoglycemia was similar in the 2 groups , but sample size limited the ability to make a definite safety assessment ." .
<http://ctro/data#ClinicalTrial_110371> <http://ctro/data#hasArm> <http://ctro/data#Arm_110440> .
<http://ctro/data#ClinicalTrial_110371> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_110605> .
<http://ctro/data#ClinicalTrial_110371> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_110673> .
<http://ctro/data#ClinicalTrial_110371> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_110741> .
# RDF export of group: Population
<http://ctro/data#Population_110389> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Population> .
<http://ctro/data#Population_110389> <http://www.w3.org/2000/01/rdf-schema#label> "Population" .
<http://ctro/data#Population_110389> <http://ctro/data#hasPrecondition> "patients with suboptimal glycemic control" .
<http://ctro/data#Ethnicity_110391> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Ethnicity> .
<http://ctro/data#Population_110389> <http://ctro/data#hasCountry> <http://ctro/data#Italy> .
<http://ctro/data#Gender_110396> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Gender> .
<http://ctro/data#Population_110389> <http://ctro/data#hasPrecondition> "patients with type 2 diabetes that is poorly controlled with oral regimens" .
<http://ctro/data#Population_110389> <http://ctro/data#hasPrecondition> "patients with type 2 diabetes who had suboptimal glycemic control while receiving stable doses of metformin and sulfonylurea" .
<http://ctro/data#Population_110389> <http://ctro/data#hasPrecondition> "adults receiving stable doses of metformin plus sulfonylurea for longer than 90 days with hemoglobin A ( 1c ) ( HbA ( 1c ) ) levels of 7 . 5 % to 10 %" .
<http://ctro/data#Population_110389> <http://ctro/data#hasPrecondition> "fasting plasma glucose levels of 6 . 7 mmol / L or greater ( > or = 120 mg / dL )" .
# RDF export of group: Endpoint
<http://ctro/data#Endpoint_110401> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_110401> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint_H" .
<http://ctro/data#Endpoint_110401> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c> .
<http://ctro/data#AggregationMethod_110403> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#Endpoint_110401> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage> .
<http://ctro/data#MeasurementDevice_110405> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_110406> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_110406> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint_H7" .
<http://ctro/data#Endpoint_110406> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c_target> .
<http://ctro/data#AggregationMethod_110408> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#Endpoint_110406> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage> .
<http://ctro/data#MeasurementDevice_110410> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_110614> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_110614> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint_FPG" .
<http://ctro/data#Endpoint_110614> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#FastingPlasmaGlucose_target> .
<http://ctro/data#AggregationMethod_110616> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#Endpoint_110614> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Millimoles_per_litre> .
<http://ctro/data#MeasurementDevice_110618> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_110682> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_110682> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint_HG" .
<http://ctro/data#Endpoint_110682> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Hypoglycemia> .
<http://ctro/data#AggregationMethod_110684> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_110685> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_110686> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_110750> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_110750> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint_Glu" .
<http://ctro/data#Glucose_110751> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Glucose> .
<http://ctro/data#Endpoint_110750> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Glucose_110751> .
<http://ctro/data#AggregationMethod_110752> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_110753> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_110754> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
# RDF export of group: Arm
<http://ctro/data#Arm_110431> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_110431> <http://www.w3.org/2000/01/rdf-schema#label> "Arm_L" .
<http://ctro/data#Arm_110431> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_110449> .
<http://ctro/data#Arm_110431> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_110488> .
<http://ctro/data#Outcome_110436> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Arm_110431> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_110461> .
<http://ctro/data#Arm_110431> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_110551> .
<http://ctro/data#Arm_110431> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_110619> .
<http://ctro/data#Arm_110431> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_110687> .
<http://ctro/data#Arm_110431> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_110755> .
<http://ctro/data#Arm_110440> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_110440> <http://www.w3.org/2000/01/rdf-schema#label> "Arm_G" .
<http://ctro/data#Arm_110440> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_110455> .
<http://ctro/data#Arm_110440> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_110515> .
<http://ctro/data#Outcome_110445> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Arm_110440> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_110461> .
<http://ctro/data#Arm_110440> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_110578> .
<http://ctro/data#Arm_110440> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_110646> .
<http://ctro/data#Arm_110440> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_110714> .
<http://ctro/data#Arm_110440> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_110755> .
# RDF export of group: Intervention
<http://ctro/data#Intervention_110449> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_110449> <http://www.w3.org/2000/01/rdf-schema#label> "Intervention_L" .
<http://ctro/data#Intervention_110449> <http://ctro/data#hasMedication> <http://ctro/data#Medication_110467> .
<http://ctro/data#Intervention_110449> <http://ctro/data#hasRelativeFreqTime> <http://ctro/data#Bedtime> .
<http://ctro/data#Intervention_110455> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_110455> <http://www.w3.org/2000/01/rdf-schema#label> "Intervention_G" .
<http://ctro/data#Intervention_110455> <http://ctro/data#hasMedication> <http://ctro/data#Medication_110474> .
<http://ctro/data#Intervention_110455> <http://ctro/data#hasRelativeFreqTime> <http://ctro/data#Bedtime> .
<http://ctro/data#Intervention_110461> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_110461> <http://www.w3.org/2000/01/rdf-schema#label> "Intervention_O" .
<http://ctro/data#Intervention_110461> <http://ctro/data#hasMedication> <http://ctro/data#Medication_110481> .
<http://ctro/data#RelativeTime_110466> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
# RDF export of group: Medication
<http://ctro/data#Medication_110467> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_110467> <http://www.w3.org/2000/01/rdf-schema#label> "Medication_L" .
<http://ctro/data#Medication_110467> <http://ctro/data#hasDrug> <http://ctro/data#LisproProtamine> .
<http://ctro/data#Medication_110467> <http://ctro/data#hasDoseValue> "10" .
<http://ctro/data#Medication_110467> <http://ctro/data#hasDoseUnit> <http://ctro/data#Int_Unit> .
<http://ctro/data#Medication_110467> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#SubcutaneousInjection> .
<http://ctro/data#Medication_110467> <http://ctro/data#hasDoseDescription> "dose titrations to target fasting glucose levels less than 5 . 6 mmol / L ( < 100 mg / dL ) in addition to stable oral regimens" .
<http://ctro/data#Medication_110474> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_110474> <http://www.w3.org/2000/01/rdf-schema#label> "Medication_G" .
<http://ctro/data#Medication_110474> <http://ctro/data#hasDrug> <http://ctro/data#InsulinGlargine> .
<http://ctro/data#Medication_110474> <http://ctro/data#hasDoseValue> "10" .
<http://ctro/data#Medication_110474> <http://ctro/data#hasDoseUnit> <http://ctro/data#Int_Unit> .
<http://ctro/data#Medication_110474> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#SubcutaneousInjection> .
<http://ctro/data#Medication_110474> <http://ctro/data#hasDoseDescription> "dose titrations to target fasting glucose levels less than 5 . 6 mmol / L ( < 100 mg / dL ) in addition to stable oral regimens" .
<http://ctro/data#Medication_110481> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_110481> <http://www.w3.org/2000/01/rdf-schema#label> "Medication_O" .
<http://ctro/data#Medication_110481> <http://ctro/data#hasDrug> <http://ctro/data#OralAntidiabeticAgent> .
<http://ctro/data#BioAndMedicalUnit_110484> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#DeliveryMethod_110485> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
# RDF export of group: Outcome
<http://ctro/data#Outcome_110488> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_110488> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome_H_L" .
<http://ctro/data#Outcome_110488> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_110401> .
<http://ctro/data#Outcome_110488> <http://ctro/data#hasChangeValue> "1 . 83" .
<http://ctro/data#Outcome_110488> <http://ctro/data#hasTimePoint> "week 36" .
<http://ctro/data#Outcome_110515> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_110515> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome_H_G" .
<http://ctro/data#Outcome_110515> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_110401> .
<http://ctro/data#Outcome_110515> <http://ctro/data#hasChangeValue> "1 . 89" .
<http://ctro/data#Outcome_110515> <http://ctro/data#hasTimePoint> "week 36" .
<http://ctro/data#Outcome_110551> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_110551> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome_H7_L" .
<http://ctro/data#Outcome_110551> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_110406> .
<http://ctro/data#Outcome_110551> <http://ctro/data#hasPercentageAffected> "62" .
<http://ctro/data#Outcome_110551> <http://ctro/data#hasTimePoint> "week 36" .
<http://ctro/data#Outcome_110578> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_110578> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome_H7_G" .
<http://ctro/data#Outcome_110578> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_110406> .
<http://ctro/data#Outcome_110578> <http://ctro/data#hasPercentageAffected> "64" .
<http://ctro/data#Outcome_110578> <http://ctro/data#hasTimePoint> "week 36" .
<http://ctro/data#Outcome_110619> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_110619> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome_FPG_L" .
<http://ctro/data#Outcome_110619> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_110614> .
<http://ctro/data#Outcome_110619> <http://ctro/data#hasPercentageAffected> "40" .
<http://ctro/data#Outcome_110619> <http://ctro/data#hasTimePoint> "week 36" .
<http://ctro/data#Outcome_110646> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_110646> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome_FPG_G" .
<http://ctro/data#Outcome_110646> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_110614> .
<http://ctro/data#Outcome_110646> <http://ctro/data#hasPercentageAffected> "64" .
<http://ctro/data#Outcome_110646> <http://ctro/data#hasTimePoint> "week 36" .
<http://ctro/data#Outcome_110687> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_110687> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome_HG_L" .
<http://ctro/data#Outcome_110687> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_110682> .
<http://ctro/data#Outcome_110687> <http://ctro/data#hasPercentageAffected> "74" .
<http://ctro/data#Outcome_110687> <http://ctro/data#hasTimePoint> "week 36" .
<http://ctro/data#Outcome_110714> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_110714> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome_HG_G" .
<http://ctro/data#Outcome_110714> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_110682> .
<http://ctro/data#Outcome_110714> <http://ctro/data#hasPercentageAffected> "67" .
<http://ctro/data#Outcome_110714> <http://ctro/data#hasTimePoint> "week 36" .
<http://ctro/data#Outcome_110755> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_110755> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome_Glu" .
<http://ctro/data#Outcome_110755> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_110750> .
<http://ctro/data#Outcome_110755> <http://ctro/data#hasObservedResult> "Continuous glucose level monitoring in the patients who had this measurement did not differ statistically ." .
# RDF export of group: DiffBetweenGroups
<http://ctro/data#DiffBetweenGroups_110542> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_110542> <http://www.w3.org/2000/01/rdf-schema#label> "DiffBetweenGroups_H" .
<http://ctro/data#DiffBetweenGroups_110542> <http://ctro/data#hasDiffGroupRelValue> "0 . 06" .
<http://ctro/data#DiffBetweenGroups_110542> <http://ctro/data#hasConfIntervalDiff> "95 % CI , - 0 . 1 to 0 . 15" .
<http://ctro/data#DiffBetweenGroups_110542> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_110488> .
<http://ctro/data#DiffBetweenGroups_110542> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_110515> .
<http://ctro/data#DiffBetweenGroups_110605> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_110605> <http://www.w3.org/2000/01/rdf-schema#label> "DiffBetweenGroups_H7" .
<http://ctro/data#DiffBetweenGroups_110605> <http://ctro/data#hasDiffGroupRelValue> "2 . 0" .
<http://ctro/data#DiffBetweenGroups_110605> <http://ctro/data#hasConfIntervalDiff> "CI , - 1 . 1 to 5 . 0" .
<http://ctro/data#DiffBetweenGroups_110605> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_110551> .
<http://ctro/data#DiffBetweenGroups_110605> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_110578> .
<http://ctro/data#DiffBetweenGroups_110673> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_110673> <http://www.w3.org/2000/01/rdf-schema#label> "DiffBetweenGroups_FPG" .
<http://ctro/data#DiffBetweenGroups_110673> <http://ctro/data#hasDiffGroupRelValue> "2 . 0" .
<http://ctro/data#DiffBetweenGroups_110673> <http://ctro/data#hasConfIntervalDiff> "CI , - 1 . 1 to 5 . 0" .
<http://ctro/data#DiffBetweenGroups_110673> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_110619> .
<http://ctro/data#DiffBetweenGroups_110673> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_110646> .
<http://ctro/data#DiffBetweenGroups_110741> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_110741> <http://www.w3.org/2000/01/rdf-schema#label> "DiffBetweenGroups_HG" .
<http://ctro/data#DiffBetweenGroups_110741> <http://ctro/data#hasDiffGroupRelValue> "7" .
<http://ctro/data#DiffBetweenGroups_110741> <http://ctro/data#hasConfIntervalDiff> "CI , - 5 to 13" .
<http://ctro/data#DiffBetweenGroups_110741> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_110687> .
<http://ctro/data#DiffBetweenGroups_110741> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_110714> .
# RDF export of group: EvidenceQuality